Virtify has received a majority investment from Tudor Ventures

Virtify, the market leader in enterprise content compliance solutions for the life sciences industry, has received a majority investment from Tudor Ventures, a Boston-based growth equity firm.

• Virtify will use the new infusion of financing to accelerate its Virtx enterprise content compliance software suite into the life sciences market by expanding operations, engineering, sales and marketing initiatives
• Virtify’s integrated product suite helps automate and streamline the complex content exchange requirements associated with bringing new pharmaceuticals to market

About Virtify

Virtify is the market leader in Enterprise Content Compliance software solutions for life sciences. Organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify’s easy-to-use Virtx software suite is the industry’s only solution to provide a secure, collaborative web-based environment for managing regulated content throughout the entire continuum – from pre-clinical through product registration to commercialization.

About Tudor Ventures

Tudor Ventures, established in 1996, is the venture capital and private equity arm of Tudor Investment Corporation, an internationally recognized, diversified investment management firm with total assets under management of approximately $11 billion. Tudor Ventures manages approximately $700 million in equity commitments. Tudor Ventures invests in information technology and rapidly growing companies providing capital for expansion, acquisition and founder liquidity.